Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study to Evaluate Safety, Efficacy of Intralesional Injection of STP705 in Patients With isSCC

ClinicalTrials.gov ID: NCT04844983

Public ClinicalTrials.gov record NCT04844983. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 8:35 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intralesional Injection of STP705 in Adult Patients With Cutaneous Squamous Cell Carcinoma in Situ (isSCC)

Study identification

NCT ID
NCT04844983
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Sirnaomics
Industry
Enrollment
44 participants

Conditions and interventions

Interventions

  • STP705 Drug
  • Placebo Saline Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 17, 2021
Primary completion
Aug 23, 2022
Completion
Dec 5, 2022
Last update posted
Mar 17, 2024

2021 – 2022

United States locations

U.S. sites
7
U.S. states
5
U.S. cities
7
Facility City State ZIP Site status
Investigate MD Scottsdale Arizona 85255
Center for Clinical and Cosmetic Research Aventura Florida 33180
Research Institute of the Southeast LLC West Palm Beach Florida 33401
Dermatology, Laser and Vein Specialists of the Carolinas Charlotte North Carolina 28207
Dermatology Associates of Knoxville Knoxville Tennessee 37909
Tennessee Clinical Research Nashville Tennessee 37215
Austin Institute for Clinical Research Pflugerville Texas 78660

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04844983, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 17, 2024 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04844983 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →